The Food and Drug Administration (FDA) visited Amphora International, Inc. in Brea on April 3 to address foodborne biological hazards, FDA data show.
According to the final report, Amphora International, Inc. was advised to take voluntary corrective measures regarding its management operations.
FDA conducts regular inspections at sites nationwide to assess whether facilities and their products comply with public health laws and regulations. Outcomes of these inspections are made publicly available.
Its website notes the FDA is the federal agency responsible for overseeing the safety and quality of human and animal drugs, biological products, medical devices and tobacco products.
Information for this story is sourced from the U.S. Food and Drug Administration. The underlying data is available here.
